| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 02/09/2005 | EP1504009A1 Fungicidal triazolopyrimidines, method for the production thereof, use thereof for controlling harmful fungi, and agents containing said fungicidal triazolopyrimidines |
| 02/09/2005 | EP1504008A1 7-aminoimidazotriazones |
| 02/09/2005 | EP1504007A1 Imidazo-triazine derivatives as ligands for gaba receptors |
| 02/09/2005 | EP1504006A1 5-ethyl-imidazo[5,1-f][1,2,4]triazin-4(3h)-ones as phosphodiesterase inhibitors |
| 02/09/2005 | EP1504005A2 Substituted pyrazolo-pyrimidine-4-ones |
| 02/09/2005 | EP1504004A2 Substituted pyrazolopyrimidines |
| 02/09/2005 | EP1503996A1 Aryl ketone pyrrolo-triazine compounds useful as kinase inhibitors |
| 02/09/2005 | EP1503979A1 Process for hydrogenating unactivated imines using ruthenium complexes as catalysts |
| 02/09/2005 | EP1503760A1 Camptothecin derivatives and polymeric conjugates thereof |
| 02/09/2005 | EP1453813A4 IMPROVED PURIFICATION OF 4, 4'(5')-DI- i t /i -BUTYLCYCLOHEXANO-18-CROWN-6 |
| 02/09/2005 | EP1385854B1 Thiazolopyrimidines and their use as modulators of chemokine receptor activity |
| 02/09/2005 | EP1280805B1 Novel imidazotriazinones and the use thereof |
| 02/09/2005 | EP1140939B1 Substituted 2-aryl-3-(heteroaryl)-imidazo[1,2-alpha]pyrimidines, and related pharmaceutical compositions and methods |
| 02/09/2005 | CN1578663A Inhibitors of histone deacetylase |
| 02/09/2005 | CN1578625A Substituted thien-3-yl-sulphonylamino(thio)carbonyl-triazolin(thi)ones |
| 02/09/2005 | CN1575816A Compounds for the treatment of female sexual dysfunction |
| 02/09/2005 | CN1188418C Cephalosporines having cyclic aminoguanidine substituents as antibiotics |
| 02/09/2005 | CN1188415C Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3', 5'-monophosphate phosphodiesterase (cGMP PDE5)for treatment of sexual dysfunction |
| 02/08/2005 | US6852858 Dissolving in solvents; precipitation; isolation; sleep disorders |
| 02/08/2005 | US6852809 Catalyst component for addition polymerization, catalyst for addition polymerization, and process for producing addition polymer |
| 02/08/2005 | US6852753 Treating hyperlipidemic condition, gallstones |
| 02/08/2005 | US6852748 Derivatives of 6,7-dihydro-5H-imidazo(1,2- alpha )imidazole-3- sulfonyl)-pyrrolidine-2-carboxylic acid amide which exhibit good inhibitory effect upon the interaction of CAMs and Leukointegrins and are thus useful in the treatment |
| 02/08/2005 | US6852745 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 02/08/2005 | US6852732 A tetrahydropyridino or piperidino heterocyclic derivative represented by the formula (I): has a high affinity for CRF receptors and is effective against diseases in which CRF is considered to be involved. (Corticotropin releasing factor |
| 02/08/2005 | US6852730 Substituted fused pyrazolecarboxylic acid arylamides and related compounds |
| 02/08/2005 | US6852725 Imidazolyl derivatives |
| 02/08/2005 | US6852722 Administering a growth hormone secretagogue. |
| 02/08/2005 | US6852721 Compounds capable of activating nicotinic cholinergic receptors; N-aryl diazabicyclic compounds such as (1S,4S)-2-(5-(3-methoxyphenoxy)-3-pyridyl)-2,5-diazabicyclo(2. 2.1)-heptane; treating central nervous system disorders |
| 02/08/2005 | US6852716 Central nervous system disorders; psychological disorders |
| 02/03/2005 | WO2005010058A1 Cucurbituril-containing polymer, stationary phase and column using the same |
| 02/03/2005 | WO2005010005A1 Triazolotriazine compounds and uses thereof |
| 02/03/2005 | WO2005010004A1 Nano-particles comprising cucurbituril derivatives, pharmaceutical composition containing the same, and process for the preparation thereof |
| 02/03/2005 | WO2005009958A1 Ppar active compounds |
| 02/03/2005 | WO2005009387A2 Azepine derivatives as pharmaceutical agents |
| 02/03/2005 | WO2003106450A8 Phenylaminopyrimidines and their use as rho-kinase inhibitors |
| 02/03/2005 | US20050027130 Rhodamine dye compounds for patterns with DNA sequences for kits |
| 02/03/2005 | US20050027122 Compounds for modulators of chemokine activity |
| 02/03/2005 | US20050026991 mono-N-substituted amide monohydroxyamide derivatives, e.g., 1-Benzyl-3-(3,4-dichloro-benzyloxy)-1H-pyrrole-2,4-dicarboxylic acid 2-[(1-benzyl-piperidin-4-yl)-amide]4-hydroxyamide, that modulate levels of gene expression in cellular systems, including cancer cells |
| 02/03/2005 | US20050026936 1,4-Dideoxy-1-C-(4-hydroxypyrrolo[3,2-d]pyrimidin-7-yl)-1,4-imino-D-ribitol derivatives or salts; parasite purine nucleoside, -hydrolase, -phosphorylase and/or phosphoribosyl transferase inhibitors; antiprotozoa, anticarcinogenic, antiinflammatory, and immunosuppressant agents; autoimmune diseases |
| 02/03/2005 | US20050026932 Adenosine A2a receptor antagonists |
| 02/03/2005 | US20050026922 For treating CNS or other disorders, including concurrent treatment of disorders such as schizophrenia and depression; side effect reduction; for example, (7R,9aS)-trans-7-[6-(2,6-Dimethyl-piperidin-1-ylmethyl)-pyridin-2-yloxymethyl]-2-(5-fluoro-benzo[d]isoxazol-3-yl)-octahydro-pyrido[1,2-a]pyrazine |
| 02/03/2005 | US20050026921 New imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions |
| 02/03/2005 | US20050026915 As melanin concentrating hormone (MCH)receptor antagonists, for prevention or treatment of obesity or eating disorders; (2E)-3-(4-chlorophenyl)-N-[2-(dimethylamino)quinolin-6-yl]prop-2-enamide |
| 02/03/2005 | US20050026910 Method of treating viral diseases |
| 02/03/2005 | US20050026901 Antihistaminic spiro compounds |
| 02/03/2005 | DE10349432A1 Neue Verwendung für Salze von DBN und DBU und von Carbonsäuresalzen New use of salts of DBN and DBU, and carboxylic acid salts |
| 02/03/2005 | CA2532798A1 Azepine derivatives as pharmaceutical agents |
| 02/03/2005 | CA2532403A1 Ppar active compounds |
| 02/03/2005 | CA2529238A1 Triazolotriazine compounds and uses thereof |
| 02/02/2005 | EP1502918A1 The use of fused ring-1,2,4-benzotriazine derivatives as herbicides or plant growth regulators for the control of undesired plants or vegetation, compounds and compositions thereof, and processes for their preparation |
| 02/02/2005 | EP1502916A1 Piperidine derivatives having ccr3 antagonism |
| 02/02/2005 | EP1501897A1 Method for the production of perylen-3,4:9,10-tetracarboxylic acid diimides and perylen-3,4:9,10-tetracarboxylic acid dianhydride and naphtalene-1,8-dicarboxylimides |
| 02/02/2005 | EP1501877A1 Fluorinated polymers |
| 02/02/2005 | EP1501834A1 Triaryl-oxy-aryl-spiro-pyrimidine-2, 4, 6-trione metalloproteinase inhibitors |
| 02/02/2005 | EP1501833A1 N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 02/02/2005 | EP1501832A1 Triazolopyrimidines |
| 02/02/2005 | EP1501831A1 Inhibitors of checkpoint kinases (wee1 and chk1) |
| 02/02/2005 | EP1501809A1 Triazole derivatives as tachykinin receptor antagonists |
| 02/02/2005 | EP1501794A1 Thiazolidinones and the use thereof as polo-like kinase inhibitors |
| 02/02/2005 | EP1362050B1 Pyrimidine derivatives for inhibition of cell-proliferation |
| 02/02/2005 | EP1303521B1 Tetrahydro-heterocycloazepinyl pyrimidine derivatives |
| 02/02/2005 | EP1299389A4 A process for preparing pyrazolopyrimidinone derivatives for the treatment of impotence |
| 02/02/2005 | CN1575191A Treatment of insulin resistance syndrome and type 2 diabetes with PDE9 inhibitors |
| 02/02/2005 | CN1575177A Cxcr3 antagonists |
| 02/02/2005 | CN1572792A Pyrazolo [4, 3-d] pyrimidine derivatives |
| 02/02/2005 | CN1572299A Agents for improving excretory potency of urinary bladder |
| 02/02/2005 | CN1187395C Bulk coloured high polymer organic material containing pyrimido-pteridine or its mixture |
| 02/02/2005 | CN1187358C Tetrahydro-heterocyclozaepinyl pyrimidine derivatives |
| 02/01/2005 | US6849734 Intermediates useful for preparing 4,6-diaminopyrido[5,4-d]pyrimidines |
| 02/01/2005 | US6849733 Compounds containing amidated guanidine derivative type functional group of structure N-C(=N)-N-CO-N-C=N or N-C(=N)-N-CO-N |
| 02/01/2005 | US6849730 Condensing a dipyrromethane-dicarbinol with a dipyrromethane in a weakly polar solvent in the presence of Lewis acid to produce a porphyrin macrocycle condensation product |
| 02/01/2005 | US6849642 Bicyclic imidazo-3-yl-amine derivatives substituted on the 6-membered ring |
| 02/01/2005 | US6849637 Matrix metalloproteases (MMPs) inhibitors such as benzyl 4-benzyl-5-oxo-4H-(1,2,4)triazolo(4,3-a)quinazol-7-ylcarboxylate for inflammatory conditions such as rheumatoid arthritis or osteoarthritis, or cancer |
| 02/01/2005 | US6849632 Heteroaryl alkyl piperazine derivatives |
| 02/01/2005 | US6849627 Including interleukin-1 and Tumor Necrosis Factor; treating rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, septic shock, cardiopulmonary dysfunction, acute respiratory disease, and cachexia |
| 02/01/2005 | US6849621 Treating: allergy, allergy-induced airway responses, congestion, hypotension, cardiovascular disease, hypotension, diseases of the GI tract, hyper and hypo motility and acidic secretion of the gastrointestinal tract, obesity, sleep |
| 02/01/2005 | US6849620 N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease |
| 02/01/2005 | US6849367 Photoconductive layer containing azo compound; electrostaticlatent image |
| 02/01/2005 | US6849270 Releasable linkage and compositions containing same |
| 02/01/2005 | US6849058 Treating rheumatoid arthritis by administering a photoactive compound such as a porphyrin systemically, directly to an affected joint or extracorporally to blood and irradiating to effect activation; returning blood to body |
| 01/27/2005 | WO2005007658A2 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 01/27/2005 | WO2005007657A2 Use of dbn and dbu salts as ionic liquids |
| 01/27/2005 | WO2005007654A1 Peptido-mimetic compounds containing rgd sequence useful as integrin inhibitors; and intermediates thereof |
| 01/27/2005 | WO2005007642A2 Novel azaheterocyclic amides useful for treating pain |
| 01/27/2005 | WO2005007634A1 3-hydroxy-4-oxo-1,2,3-triazines and derivatives thereof for amide and ester bond formation |
| 01/27/2005 | WO2005007622A2 OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT, PROCESS FOR PRODUCING THE SAME, AND PROCESS FOR PRODUCING OPTICALLY ACTIVE α-AMINO ACID DERIVATIVE WITH THE SAME |
| 01/27/2005 | WO2005007099A2 Pkb inhibitors as anti-tumor agents |
| 01/27/2005 | WO2005007085A2 Pyrazolo pyrimidine derivatives and methods of use thereof |
| 01/27/2005 | WO2004104006A3 PROCESS FOR SYNTHESIZING β-LACTAMASE INHIBITOR IN INTERMEDIATES |
| 01/27/2005 | WO2004091613A3 Substituted phenyl acetamides and their use as protease inhibitors |
| 01/27/2005 | WO2004082606A3 Fused pyrrole compounds |
| 01/27/2005 | US20050020659 Substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonists |
| 01/27/2005 | US20050020648 "PGI2-preferring" (IP) receptors; p-(imidazolin-2-ylamino-optional alkyl)phenyl p'-substituted ethers or sulfides, e.g., 4,5-Dihydro-1H-imidazol-2-yl)-[4-(4-isopropoxy-phenylsulfanyl)-phenyl]-amine, used to induce hyperalgesia |
| 01/27/2005 | US20050020595 Compounds, methods and pharmaceutical compositions for inhibiting PARP |
| 01/27/2005 | US20050020592 Substituted heterocyclic compounds and methods of use |
| 01/27/2005 | US20050020579 Novel crystalline tricyclic triazolobenzazepine derivative |
| 01/27/2005 | US20050020578 Oxidoreductase enzyme inhibitors such as (R)-1-[4-(2-methyl-4-phenyl-5,8-dihydro-6H-pyrido[3,4-d]pyrimidin-7-yl)-pyrimidin-2-yl-ethanol, used as antidiabetic agents |
| 01/27/2005 | US20050020574 dipeptidylpeptidase-IV inhibitors; treatment of diabetes and obesity |
| 01/27/2005 | US20050020573 5HT2c receptor modulators |
| 01/27/2005 | US20050020572 Therapy for bacteria infections |